The global home sleep apnea testing market was worth US$ 0.7 Billion in the year 2021 and expected to reach US$ 3.09 Billion by the year 2032 at a remarkable CAGR of 14.4% between 2022 and 2032.
Sleep apnea testing, as the name suggests, is capable of diagnosing and calculating severity of disease (related to sleep disorders) by monitoring breathing levels and oxygen for measuring pauses in breathing. If it’s home sleep apnea testing, it means that testing is done across the homecare settings.
With rise in the number of patients who are diagnosed with various sleep disorders along with the other associated co-morbidities are expected to accelerate the sleep apnea testing market in the near future. This is evident from the fact that the American Sleep Association states that almost 50-70 Million US adults suffer from sleep disorder; out of which 25 Million contract obstructive sleep apnea.
Download a sample to obtain additional highlights and key points on various market segments and their impact in the coming years @
https://www.futuremarketinsights.com/reports/sample/rep-gb-10060
Wearable, advanced sleep apnea testing devices are being designed with user-friendly design. Some of the examples include Lofta WatchPAT.
Plus, there are telemedicine options like at-home sleep studies available for diagnosing symptoms. They also help in selecting the appropriate CPAP (continuous positive airway pressure) devices and access the procedure of ongoing monitoring.
At the same time, the fact that home sleep apnea testing devices come with risks of exposure to particulates and chemicals can’t be ignored. They may, in turn, result in irritation of respiratory tract or asthma. These factors may restrain the home sleep apnea testing market in the near future.
Future Market Insights has walked through these facts with insights in its latest market study entitled ‘Home Sleep Apnea Testing Market’. It has its team of analysts and consultants to deploy a bottom-up approach in its primary, secondary, and tertiary modes of research.
“With almost all the geographies witnessing an increase in the number of insomniacs, the global home sleep apnea testing market is expected to grow at a grand scale in the near future.
Key Takeaways from Home Sleep Apnea Testing market
- North America holds the largest market share with the US being subject to an increasing number of sleep disorders.
- Europe holds the second-largest market share with conducive reimbursement scenes in France, Germany, and the UK.
- The Asia-Pacific is expected to grow at a noteworthy rate in the home sleep apnea testing market. This could be credited to India and China being at the forefront in this regard.
Are you looking for customized information related to the latest trends, drivers, and challenges? Speak to Our Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-10060
Competitive Testing
- Philips Respironics has its Alice NightOne; which comes across as a simple to use HST (home sleep testing) device designed for helping patients get the testing done with immediate effect.
- Resmed offers Apnea Link Air – a cost-effective home sleep testing device.
- Philips, in September 2019, did announced launching NightBalance – a prescription sleep position therapy device for those suffering from positional obstructive sleep apnea. It has also come up with a positional therapy that makes use of gentle vibrations for altering sleeping positions to aid in prevention of apneas.
- The other players of home sleep apnea testing market include Sleep Med Inc., Curative Medical Inc., and NovaSom.
What does the Report test?
- The research study is based on product type (CPAP devices, BPAP devices, ASV (Adaptive Servo-Ventilation) devices, and mandibular advancement devices), and by indication (obstructive sleep apnea, insomnia, cognitive impairment, and daytime sleepiness).
- With increasing incidences of chronic sinusitis and obesity, the global home sleep apnea testing market is bound to grow on an irreversible note in the forecast period.
Grow your profit margin with Future Market Insights – Buy the report@ https://www.futuremarketinsights.com/checkout/10060
Key Players:
NovaSom,
Curative Medical Inc,
Phillips Respironics, among others
About FMI:
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs
